PortfoliosLab logoPortfoliosLab logo
ELVN vs. MP
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ELVN vs. MP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enliven Therapeutics Inc. (ELVN) and MP Materials Corp. (MP). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ELVN vs. MP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ELVN
Enliven Therapeutics Inc.
154.55%-31.56%62.57%-15.40%81.78%-89.80%-46.10%
MP
MP Materials Corp.
-4.47%223.85%-21.41%-18.25%-46.54%41.19%221.70%

Fundamentals

Market Cap

ELVN:

$2.22B

MP:

$9.61B

EPS

ELVN:

-$1.82

MP:

-$0.48

PB Ratio

ELVN:

4.83

MP:

6.14

Total Revenue (TTM)

ELVN:

$0.00

MP:

$224.44M

Gross Profit (TTM)

ELVN:

$0.00

MP:

-$18.14M

EBITDA (TTM)

ELVN:

-$119.66M

MP:

-$19.06M

Returns By Period

In the year-to-date period, ELVN achieves a 154.55% return, which is significantly higher than MP's -4.47% return.


ELVN

1D
7.13%
1M
32.03%
YTD
154.55%
6M
91.50%
1Y
99.19%
3Y*
21.42%
5Y*
3.11%
10Y*

MP

1D
5.86%
1M
-18.02%
YTD
-4.47%
6M
-28.05%
1Y
97.71%
3Y*
19.63%
5Y*
6.54%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Enliven Therapeutics Inc.

MP Materials Corp.

Return for Risk

ELVN vs. MP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVN
ELVN Risk / Return Rank: 7979
Overall Rank
ELVN Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
ELVN Sortino Ratio Rank: 8383
Sortino Ratio Rank
ELVN Omega Ratio Rank: 7676
Omega Ratio Rank
ELVN Calmar Ratio Rank: 8080
Calmar Ratio Rank
ELVN Martin Ratio Rank: 8080
Martin Ratio Rank

MP
MP Risk / Return Rank: 7575
Overall Rank
MP Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
MP Sortino Ratio Rank: 8282
Sortino Ratio Rank
MP Omega Ratio Rank: 7575
Omega Ratio Rank
MP Calmar Ratio Rank: 7474
Calmar Ratio Rank
MP Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVN vs. MP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enliven Therapeutics Inc. (ELVN) and MP Materials Corp. (MP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ELVNMPDifference

Sharpe ratio

Return per unit of total volatility

1.16

1.00

+0.15

Sortino ratio

Return per unit of downside risk

2.27

2.16

+0.10

Omega ratio

Gain probability vs. loss probability

1.26

1.24

+0.02

Calmar ratio

Return relative to maximum drawdown

2.34

1.60

+0.74

Martin ratio

Return relative to average drawdown

6.04

3.04

+3.00

ELVN vs. MP - Sharpe Ratio Comparison

The current ELVN Sharpe Ratio is 1.16, which is comparable to the MP Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of ELVN and MP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ELVNMPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.16

1.00

+0.15

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

0.09

-0.06

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.08

0.43

-0.51

Correlation

The correlation between ELVN and MP is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ELVN vs. MP - Dividend Comparison

Neither ELVN nor MP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ELVN vs. MP - Drawdown Comparison

The maximum ELVN drawdown since its inception was -98.20%, which is greater than MP's maximum drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for ELVN and MP.


Loading graphics...

Drawdown Indicators


ELVNMPDifference

Max Drawdown

Largest peak-to-trough decline

-98.20%

-81.99%

-16.21%

Max Drawdown (1Y)

Largest decline over 1 year

-36.84%

-53.79%

+16.95%

Max Drawdown (5Y)

Largest decline over 5 years

-89.05%

-81.99%

-7.06%

Current Drawdown

Current decline from peak

-82.14%

-51.08%

-31.06%

Average Drawdown

Average peak-to-trough decline

-84.32%

-42.80%

-41.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.24%

28.20%

-13.96%

Volatility

ELVN vs. MP - Volatility Comparison

Enliven Therapeutics Inc. (ELVN) has a higher volatility of 24.29% compared to MP Materials Corp. (MP) at 20.67%. This indicates that ELVN's price experiences larger fluctuations and is considered to be riskier than MP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ELVNMPDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.29%

20.67%

+3.62%

Volatility (6M)

Calculated over the trailing 6-month period

62.98%

57.18%

+5.80%

Volatility (1Y)

Calculated over the trailing 1-year period

86.57%

98.01%

-11.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.92%

69.40%

+16.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

88.74%

72.59%

+16.15%

Financials

ELVN vs. MP - Financials Comparison

This section allows you to compare key financial metrics between Enliven Therapeutics Inc. and MP Materials Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
52.69M
(ELVN) Total Revenue
(MP) Total Revenue
Values in USD except per share items